Data regarding hidradenitis suppurativa (HS)‐related expenditure is limited and non‐
homogeneous, but HS does incur significant expenses. We performed a systematic review …

Introduction Hidradenitis suppurativa (HS) has a profound negative impact on patients'
health-related quality of life (HRQoL). Here we summarize the evidence on HRQoL and …

Introduction Hidradenitis suppurativa (HS) is a chronic, autoinflammatory skin disease
associated with many comorbidities. One biologic (adalimumab) is approved for HS. This …

Background Cost-of-illness studies are widely used for healthcare decision-making in
chronic conditions. Our aim was to assess the cost-of-illness of adult atopic dermatitis (AD) …

Abstract Background and Objective Hidradenitis suppurativa is a chronic inflammatory skin
disease that can lead to a substantial reduction in quality of life. Recent studies revealed …

2. Materials and methods In this study, the same DCE questionnaire was used that elicited
the treatment preferences of HS patients in Europe Citation 12. In the DCE questionnaire …

Hidradenitis suppurativa (HS)/Acne inversa (AI) geht mit zahlreichen und relevanten
Einschränkungen der Lebensqualität für die Betroffenen und ihre Angehörigen einher …

Background Real-world knowledge of the burden of hidradenitis suppurativa (HS) on
patients remains limited. Objectives To measure the impact of adalimumab on moderate-to …

Background Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease affecting
approximately 1% of the population. The patient journey through the German health care …

The prevalence of primary axillary hyperhidrosis in Japan is 5.75%(males, 6.60%; females,
4.72%) in the population aged 5–64 years. No study on comprehensively evaluated direct …